COVID‐19 in older adults: What are the differences with younger patients?

Abstract

Aim The present study aimed both to gain knowledge on the distinctive clinical characteristics of older adults with coronavirus disease 2019 (COVID‐19), in comparison with those of younger patients, and to identify risk factors for mortality. Methods A retrospective observational study was carried out of patients consecutively admitted to Doctor Peset University Hospital, Valencia (Spain) for COVID‐19 from 11 March to 28 April 2020. Every case was diagnosed by reverse transcription polymerase chain reaction or by serology test to detect antibodies. Demographic details, clinical characteristics, laboratory findings on admission and complications of each case were collected from electronic medical records. Results The dataset comprised 340 patients. Of them, 152 (44.6%) were aged >70 years. Comorbidities were more common in the older groups. Confusion was more common in older adults, whereas typical symptoms of COVID‐19, such as fever, cough and myalgia, were less common. Oxygen saturation ≤93% on room air, neutrophilia, D‐dimer >0.5 μg/mL, creatinine >1.5 mg/dL, lactate dehydrogenase ≥250 U/L and elevation of creatine kinase were higher in the older adult groups. Complications during hospitalization, such as acute respiratory distress syndrome (53.3% vs 33.2%, P < 0.001), acute kidney injury (11.8% vs 5.3%; P = 0.030) and mortality (28.9% vs 6.5%; P < 0.001) were more common in patients aged >70 years. Oxygen saturation ≤93% on room air on admission was a predictor of mortality (odds ratio 11.65, 95% confidence interval 3.26–41.66, P < 0.001) in patients aged >70 years. Conclusions Older adults with COVID‐19 have more atypical presentation, more complications and higher mortality. Oxygen saturation ≤93% on room air on admission is a predictive factor of death. Geriatr Gerontol Int 2020; ••: ••–•• .

Early detection of COVID-19 in the UK using self-reported symptoms: a large-scale, prospective, epidemiological surveillance study

“…The differences in feature relevance could also be explained by the small number of people in the age groups used, specifically older people who might be less prone to register their symptoms regularly, and fewer evident and aggressive symptoms in younger participants than in older participants. 24,25 Therefore, future research should focus on the development of submodels targeting the specificities of the age subgroups that showed signifi cantly different features. Nevertheless, the prediction of COVID-19 diagnosis across all the age groups had a consistently high certainty.…”

Longitudinal Analysis and Comparison of Six Serological Assays up to Eight Months Post-COVID-19 Diagnosis

“…We did not observe any difference between men and women for the same assay but did observe a difference between individuals aged less or more than 65 years and those hospitalized or not for COVID-19. These two criteria are strongly linked, as a greater proportion of people over 65 years old are hospitalized for COVID-19 [ 12 ].…”

Bacterial and Fungal Co-Infections among ICU COVID-19 Hospitalized Patients in a Palestinian Hospital: Incidence and Antimicrobial Stewardship

“…The overall mortality rate in this study was 8.1% (26), while 72.9% (234) of the patients remained in the ICU for 1-6 days. Each patient was infected with one type of bacteria or fungi; presented as respiratory infection, bacteremia, and skin infections.…”

“…Numerous investigations found that older COVID-19 patients aged ≥ 50 years were correlated with higher risk for severe signs, atypical presentation, the opportunity for co-infections and higher fatality rates compared to patients with <50 years of age, and the rate usually increases rapidly with age; it is not surprising due to the drop in natural immunity by age, associated comorbidities and it is believed that older people are prone to adverse drug reactions. In general, people of different ages are prone to get infected with the COVID virus (25) (26). A review reported a twice higher fatality rate in males compared to females; it has stated that male patients may have higher ACE-2 enzyme activity, directed by male sex hormones, contributing to more risk for SARS-CoV-2 infection and worsening clinical outcomes (27).…”